Schering-Plough Aims to Triple Japan Sales by 2010

U.S. drugmaker Schering-Plough Corp. said it aims to triple its sales in Japan over the next five years by launching key medicines such as cholesterol fighter Zetia. Chief Executive Fred Hassan told Reuters in an interview that Schering-Plough, whose Japanese unit posted 36.8 billion yen ($346 million) in drug sales in 2004 and ranked 52nd locally, wants to be among the top 25 makers in the world's second-largest drug market by 2010.

Yahoo News (http://asia.news.yahoo.com/050328/3/1yfev.html)